Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Does the EU Pharmaceutical Sector Inquiry Provide Proof of the Need for a Centralised Patent Court?

This article was originally published in SRA

Executive Summary

Generic drug companies hoping to have cases heard against “weak patents” in the UK courts may be well advised to steer clear of Lord Justice Robin Jacob. A judge in the Court of Appeal, and one of the UK’s most experienced patent judges, Lord Justice Jacob recently suggested that the European Commission’s inquiry into competition in the pharmaceutical sector was simply “a waste of time”.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS114070

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel